Statistics
Publications
2
Citations
1K
H-Index
2
Active since
2003
Affiliations
Pfizer (United States)(Current)
Chang Shang-Poa is an author at Pfizer (United States) specializing in jak-stat signaling pathway, immunosuppressive therapy, and immunosuppression.
Publications per year
2003–2010
2
2
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 670 citations · Full text
Medicine, Immunology, Pharmacology +17
Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 335 citations · Full text
1–2 of 2